HSA
CDNA icon

Hussman Strategic Advisors’s CareDx CDNA Stock Holding History

Hussman Strategic Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-126,000
Closed -$2.24M – 227
2025
Q1 		$2.24M Buy
+126,000
New +$2.71M 0.54% 67

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Hussman Strategic Advisors's CDNA Position: Q2 2025 in Review

Hussman Strategic Advisors sold out of CareDx (CDNA) in Q2 2025, closing a stake of 126,000 shares — an estimated $2.24M sold.

Hussman Strategic Advisors first reported a position in CDNA in Q1 2025 and held it in 1 quarter. The position peaked at $2.24M in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Hussman Strategic Advisors reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Hussman Strategic Advisors sold 126,000 CareDx shares in Q2 2025, an estimated $2.24M.
  • Hussman Strategic Advisors first reported a position in CareDx in Q1 2025 and held it in 1 quarter.
  • Hussman Strategic Advisors's CareDx position peaked at $2.24M in Q1 2025.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Hussman Strategic Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.